1. Home
  2. CYTK vs GATX Comparison

CYTK vs GATX Comparison

Compare CYTK & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • GATX
  • Stock Information
  • Founded
  • CYTK 1997
  • GATX 1898
  • Country
  • CYTK United States
  • GATX United States
  • Employees
  • CYTK N/A
  • GATX N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • GATX Transportation Services
  • Sector
  • CYTK Health Care
  • GATX Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • GATX Nasdaq
  • Market Cap
  • CYTK 5.6B
  • GATX 5.6B
  • IPO Year
  • CYTK 2004
  • GATX N/A
  • Fundamental
  • Price
  • CYTK $32.48
  • GATX $145.62
  • Analyst Decision
  • CYTK Buy
  • GATX Buy
  • Analyst Count
  • CYTK 19
  • GATX 2
  • Target Price
  • CYTK $77.33
  • GATX $172.50
  • AVG Volume (30 Days)
  • CYTK 2.4M
  • GATX 211.7K
  • Earning Date
  • CYTK 05-06-2025
  • GATX 04-23-2025
  • Dividend Yield
  • CYTK N/A
  • GATX 1.69%
  • EPS Growth
  • CYTK N/A
  • GATX 12.52
  • EPS
  • CYTK N/A
  • GATX 7.90
  • Revenue
  • CYTK $19,218,000.00
  • GATX $1,627,200,000.00
  • Revenue This Year
  • CYTK $55.84
  • GATX $10.06
  • Revenue Next Year
  • CYTK $646.96
  • GATX $5.67
  • P/E Ratio
  • CYTK N/A
  • GATX $18.28
  • Revenue Growth
  • CYTK 412.21
  • GATX 12.07
  • 52 Week Low
  • CYTK $31.67
  • GATX $127.00
  • 52 Week High
  • CYTK $68.44
  • GATX $168.89
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 31.23
  • GATX 45.67
  • Support Level
  • CYTK $34.88
  • GATX $144.19
  • Resistance Level
  • CYTK $43.51
  • GATX $149.79
  • Average True Range (ATR)
  • CYTK 2.00
  • GATX 3.71
  • MACD
  • CYTK -0.67
  • GATX 0.41
  • Stochastic Oscillator
  • CYTK 6.84
  • GATX 47.46

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About GATX GATX Corporation

GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.

Share on Social Networks: